Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucous membrane pemphigoid: an update.

Margherita E Eschle-Meniconi1, Sumera R Ahmad, C Stephen Foster

  • 1Massachusetts Eye Research and Surgery Institute, Boston, Massachusetts, USA, and Medical School of Aga Khan University, Karachi, Pakistan.

Current Opinion in Ophthalmology
|September 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 2026 Multisociety Acute Pulmonary Embolism Guidelines: An Expert Perspective.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Mechanical Thrombectomy for Intermediate- and High-Risk Pulmonary Embolism: A Retrospective Observational Cohort Study.

Journal of intensive care medicine·2026
Same author

Saliva as a noninvasive diagnostic for ocular sarcoidosis.

Journal of leukocyte biology·2026
Same author

Humanizing care in the ICU: implementation of the Get to Know Me Board in patient care.

Frontiers in medicine·2026
Same author

Oral cyclophosphamide as part of the treatment regimen in patients with nonparaneoplastic autoimmune retinopathy secondary to birdshot chorioretinopathy.

Oman journal of ophthalmology·2026
Same author

How to interpret low-dose valacyclovir for postherpetic neuralgia in the Zoster Eye Disease Study-a randomized clinical trial.

Annals of translational medicine·2026
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Recent research on mucous membrane pemphigoid reveals new insights into its pathogenesis and treatment. Advances include understanding antigen identification, improved diagnostic methods, and novel therapeutic strategies for ocular cicatricial pemphigoid.

Area of Science:

  • Dermatology
  • Immunology
  • Ophthalmology

Background:

  • Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering disease.
  • It primarily affects mucous membranes, but can also involve the skin.
  • Ocular cicatricial pemphigoid (OCP) is a severe subtype leading to blindness.

Purpose of the Study:

  • To review recent advances in the understanding and management of mucous membrane pemphigoid.
  • To highlight key findings published between June 2004 and May 2005.

Main Methods:

  • Literature review of articles on MMP and OCP.
  • Analysis of findings related to immunopathology, diagnostics, and therapeutics.

Main Results:

  • Decreased mucin glycosylation in OCP.

Related Experiment Videos

  • Increased expression of adhesion molecules (VCAM, ICAM-1) in skin MMP.
  • Identification of autoreactive T cells to BP180.
  • Development of a sensitive ELISA for anti-laminin-5 autoantibodies.
  • Intravenous immunoglobulin showed superior efficacy and safety for OCP treatment.
  • Successful surgical interventions for cicatrizing conjunctivitis and corneal stem cell deficiency.

    • Conclusions:

    • Significant progress has been made in understanding MMP pathogenesis.
    • Novel diagnostic tools and treatment strategies offer improved patient outcomes.
    • Further research is ongoing to fully elucidate MMP and its subtypes.